Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  1997-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/JCEM.82.2.3722PMID 9024248
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome.

  1996cited by this paper
• Can metformin reduce insulin resistance in polycystic ovary syndrome?

  1996cited by this paper
• Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion.

  1995cited by this paper
• Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women.

  1995cited by this paper
• Insulin secretion and clearance during low-dose graded glucose infusion.

  1995cited by this paper
• Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy.

  1994influential reference
• Body fat distribution has weight-independent effects on clinical, hormonal, and metabolic features of women with polycystic ovary syndrome.

  1994influential reference
• Defects in beta-cell function in functional ovarian hyperandrogenism.

  1993cited by this paper
• Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism.

  1993cited by this paper
• 17‐Hydroxyprogesterone response to buserelin testing in the polycystic ovary syndrome

  1993cited by this paper
• Metformin effects on peripheral sensitivity to insulin in non diabetic obese subjects.

  1993cited by this paper
• Quantification of the Relationship Between Insulin Sensitivity and β-Cell Function in Human Subjects: Evidence for a Hyperbolic Function

  1993cited by this paper
• Prevalence of and Etiological Factors in Polycystic Ovarian Syndrome

  1993cited by this paper
• Insulin actions on ovarian steroidogenesis are not modulated by metformin.

  1993cited by this paper
• Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellitus.

  1993cited by this paper
• Abnormalities in the ultradian oscillations of insulin secretion and glucose levels in Type 2 (non-insulin-dependent) diabetic patients

  1992cited by this paper
• Detection of functional ovarian hyperandrogenism in women with androgen excess.

  1992cited by this paper
• Estimation of Insulin Secretion Rates from C-Peptide Levels: Comparison of Individual and Standard Kinetic Parameters for C-Peptide Clearance

  1992cited by this paper
• Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome

  1992cited by this paper
• Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome.

  1992cited by this paper
• Intravenous glucose tolerance test-derived insulin sensitivity changes during the menstrual cycle.

  1991cited by this paper
• Entrainment of pulsatile insulin secretion by oscillatory glucose infusion.

  1991cited by this paper
• Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome.

  1990cited by this paper
• Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition.

  1990cited by this paper
• Dysregulation of cytochrome P450c17α as the cause of polycystic ovarian syndrome

  1990cited by this paper
• Toward Physiological Understanding of Glucose Tolerance: Minimal-Model Approach

  1989cited by this paper
• Menstrual cyclicity has a profound effect on glucose homeostasis.

  1989cited by this paper
• Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome.

  1989cited by this paper
• Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome.

  1989cited by this paper
• Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells.

  1988cited by this paper
• Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia.

  1987cited by this paper
• Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients.

  1986cited by this paper
• Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.

  1986cited by this paper
• Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism.

  1986cited by this paper
• The changing ratio of bioactive to immunoreactive luteinizing hormone (LH) through puberty principally reflects changing LH radioimmunoassay dose-response characteristics.

  1985cited by this paper
• Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose.

  1981influential reference
• Estradiol-testosterone binding interactions and free plasma estradiol under physiological conditions.

  1981cited by this paper
• Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior.

  1980cited by this paper
• Characterization of Seven C-peptide Antisera

  1978cited by this paper
• Insulin and Glucose Responses to Identical Oral Glucose Tolerance Tests Performed Forty-eight Hours Apart

  1974cited by this paper
• Spectral analysis and its applications

  1968cited by this paper
• Reproducibility of the Oral Glucose Tolerance Test

  1965cited by this paper
• Immunoassay of Insulin: Two Antibody System: Plasma Insulin Levels of Normal, Subdiabetic and Diabetic Rats

  1963cited by this paper

• The Search for the Causes of Common Hyperandrogenism, 1965 to circa 2015.

  2024cites this paper
• A novel action of insulin sensitizing drug as a potential promotor of preovulatory follicles, ovulation rate and prolificacy in sheep

  2023cites this paper
• Nonalcoholic fatty liver disease and obstructive sleep apnea in women with polycystic ovary syndrome.

  2022cites this paper
• Compendium of polycystic ovarian syndrome and its relevance in glycation and diabetes

  2022cites this paper
• The polycystic ovary syndrome: the first 150 years of study

  2022cites this paper
• Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin

  2022influential citation
• Metformin Improves Ovarian Function and Increases Egg Production in Broiler Breeder Hens

  2022cites this paper
• Polycystic ovarian syndrome and miscarriage in IVF: systematic revision of the literature and meta-analysis

  2022cites this paper
• Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals

  2021cites this paper
• Effect of Metformin on Anthropometric Measurements and Hormonal and Biochemical Profile in Patients with Prediabetes

  2021cites this paper
• Infertility Riding on Polycystic Ovarian Syndrome (PCOS): A Review of Treatment Modalities

  2021cites this paper
• Puberty in the Female and Its Disorders

  2021cites this paper
• Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome.

  2021cites this paper
• Metformin attenuates steroidogenesis in ovarian follicles of the broiler breeder hen.

  2020cites this paper
• Metformin Efficacy in Treatment of Chronic Anovulation in Women with Metabolic Disorders

  2020cites this paper
• Effect of Metformin Treatment on the Serum Levels of Vitamin B12 andFolic Acid in Patients with Polycystic Ovary Syndrome

  2020cites this paper
• A randomized trial of dapagliflozin and metformin, alone and combined, in overweight women after gestational diabetes mellitus.

  2020cites this paper
• Effect of metformin and flutamide on insulin, lipogenic and androgen-estrogen signaling, and cardiometabolic risk in a PCOS-prone metabolic syndrome rodent model.

  2019cites this paper
• Nonalcoholic fatty liver disease in women with polycystic ovary syndrome

  2019cites this paper
• Polycystic Ovary Syndrome and Hyperandrogenic States

  2019cites this paper
• Effect of metformin and flutamide on insulin, lipogenic and androgen-estrogen signaling, and cardiometabolic risk in a PCOS-prone metabolic syndrome rodent model

  2018influential citation
• Serum Ghrelin and Adiponectin Level With Insulin Resistance Parameters in Obese Patients with Polycystic Ovary Syndrome Treated By Metformin

  2018cites this paper
• The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome

  2018cites this paper
• Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice

  2018cites this paper
• The effect of metformin on clinical features of women with polycystic ovary syndrome

  2018cites this paper
• Polycystic Ovary Syndrome in Adolescents

  2018cites this paper
• SHORT-TERM SITAGLIPTIN-METFORMIN THERAPY IS MORE EFFECTIVE THAN METFORMIN OR PLACEBO IN PRIOR GESTATIONAL DIABETIC WOMEN WITH IMPAIRED GLUCOSE REGULATION.

  2018cites this paper
• Raw red onion intake and insulin resistance markers in overweight or obese patients with polycystic ovary syndrome: a randomized controlled-clinical trial

  2018cites this paper
• Insulin Sensitizers Modulate GnRH Receptor Expression in PCOS Rats.

  2018cites this paper
• Clinical outcome of metformin treatment in patients of acanthosis nigricans with insulin resistance

  2017cites this paper
• Short-term therapy with combination dipeptidyl peptidase-4 inhibitor saxagliptin/metformin extended release (XR) is superior to saxagliptin or metformin XR monotherapy in prediabetic women with polycystic ovary syndrome: a single-blind, randomized, pilot study.

  2017cites this paper
• Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome

  2017cites this paper
• Effect of metformin by employing 2-hour postload insulin for measuring insulin resistance in Taiwanese women with polycystic ovary syndrome.

  2017cites this paper
• Effects of metformin, glyburide and their combination on lipid profile in NIDDM patients

  2017cites this paper
• Use of in vitro maturation in a clinical setting: Patient populations and outcomes

  2017cites this paper
• Effect of Metformin and Clomiphene Citrate in Improving Fertility in Subfertile Women with Polycystic Ovary Syndrome: A Randomized Controlled Trial

  2016cites this paper
• Study of Effect of Metformin in PCOS Patients

  2016cites this paper
• Effect of Metformin on FSH, LH and Prolactin Levels in Patients with Polycystic Ovarian Syndrome

  2016cites this paper
• The role of variants regulating metformin transport and action in women with polycystic ovary syndrome.

  2016cites this paper
• Effect of Long Protocol versus Short Protocol of Metformin Therapy in Pregnancy Outcomes in Polycystic Ovarian Syndrome - A Comparative Study

  2016cites this paper
• Effect of Administration of Metformin on Lipid Profile in Patients with Polycystic Ovary Syndrome after Six Months of Treatment

  2016cites this paper
• Clinico-biochemical characteristics of 229 Portuguese infertile women with polycystic ovary syndrome: clinical relevance and relationship with fertility treatment results.

  2016cites this paper
• THE ROLE OF ANTI-MULLERIAN HORMONE IN THE EVALUATION OF THE EFFECTIVENESS OF METFORMIN HYDROCHLORIDE THERAPY IN POLYCYSTIC OVARIAN SYNDROME

  2016cites this paper
• Poly Cystic Ovarian Syndrome: An Updated Overview

  2016cites this paper
• GENETIC AND EPIGENETIC MECHANISMS OF COMPLEX REPRODUCTIVE DISORDERS

  2016cites this paper
• A clinical comparative study on the effects of metformin and pioglitazone on clinical symptoms in cases of polycystic ovarian syndrome

  2016cites this paper
• HEART RATE VARIABILITY AND LIPID PROFILE IN NON OBESE YOUNG INDIAN WOMEN WITH POLYCYSTIC OVARY SYNDROME

  2015cites this paper
• Clomiphene citrate, metformin or a combination of both as the first line ovulation induction drug for Asian Indian women with polycystic ovarian syndrome: A randomized controlled trial

  2015cites this paper
• Implant-supported Overdenture using Resilient Reliner

  2015cites this paper
• Benefits of short-term structured exercise in non-overweight women with polycystic ovary syndrome: a prospective randomized controlled study

  2015cites this paper
• The Reconstruction Purposes Implant Deficits Bone Ridge Edentulous

  2015cites this paper
• Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome

  2015cites this paper
• Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome

  2015cites this paper
• Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome

  2015cites this paper
• Bedeutung der Insulinresistenz beim polyzystischen Ovarsyndrom – prä- und postkonzeptionell

  2015cites this paper
• Comparative Study between Metformin and Laparoscopic Ovarian Drilling for Ovulation Induction, Achievement of Pregnancy and Live Birth in Asian Women with Polycystic Ovarian Syndrome: A Prospective Trial

  2014cites this paper
• Management of Type 2 diabetes mellitus in primary care

  2014cites this paper
• Metformin improves glucose effectiveness, not insulin sensitivity: predicting treatment response in women with polycystic ovary syndrome in an open-label, interventional study.

  2014cites this paper
• Metformin induces a prompt decrease in LH-stimulated testosterone response in women with PCOS independent of its insulin-sensitizing effects

  2014cites this paper
• Polycystic Ovarian Syndrome: Leading Cause of Female Infertility.

  2014cites this paper
• Polycystic Ovary Syndrome, Obesity and Insulin Resistance

  2014cites this paper
• Pretreatment and co‐administration of oral anti‐diabetic agent with clomiphene citrate or rFSH for ovulation induction in clomiphene‐citrate‐resistant polycystic ovary syndrome

  2013cites this paper
• Menstrual Disorders and Hyperandrogenism in Adolescence

  2013cites this paper
• Ethinyl estradiol–drospirenone vs ethinyl estradiol–drospirenone plus metformin in the treatment of lean women with polycystic ovary syndrome

  2013cites this paper
• Metabolic and other effects of pioglitazone as an add-on therapy to metformin in the treatment of polycystic ovary syndrome (PCOS)

  2013cites this paper
• A Detailed Study on Poly Cystic Ovarian Syndrome and It's Treatment With Natural Products

  2013cites this paper
• Use of Rosiglitazone for Clomiphene Resistant Polycystic Ovary Syndrome (PCOS): A Randomized Controlled Trial

  2013cites this paper
• Metabolic Changes and Hormonal Disturbances in Polycystic Ovarian Syndrome Rats and the Amelioration Effects of Metformin and/or Cinnamon Extraction

  2013cites this paper
• Effects of metformin plus rosuvastatin on hyperandrogenism in polycystic ovary syndrome patients with hyperlipidemia and impaired glucose tolerance

  2012cites this paper
• Metformin versus lifestyle changes in treating women with polycystic ovary syndrome

  2012cites this paper
• Effects of elevated testosterone levels on reproductive neuroendocrine function and behavior in female rheus macaques (macaca mulatta)

  2012influential citation
• Insulin Resistance, Polycystic Ovary Syndrome and Metformin

  2012cites this paper
• Effect of Lifestyle Modification and Metformin Therapy on Emerging Cardiovascular Risk Factors in Overweight Indian Women with Polycystic Ovary Syndrome

  2012cites this paper
• Comparative Study of Metformin Versus Clomiphine Citrate for Ovulation Induction in Polycystic Ovary Syndrome at Lady Willingdon Hospital Lahore

  2012cites this paper
• Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome

  2011cites this paper
• The metabolic aspects of polycystic ovary syndrome

  2011cites this paper
• Effect of dose escalation of metformin on clinical features, insulin sensitivity and androgen profile in polycystic ovary syndrome.

  2011cites this paper
• Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome.

  2011cites this paper
• Surgical Management Options for Patients with Infertility and Endometriosis

  2010cites this paper
• Effects of pioglitazone on ovarian stromal blood flow, ovarian stimulation, and in vitro fertilization outcome in patients with polycystic ovary syndrome.

  2010cites this paper
• Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial

  2010cites this paper
• Insulin Receptor and its Relationship with Different Forms of Insulin Resistance

  2010cites this paper
• Metformin: A Therapeutic Opportunity in Breast Cancer

  2010cites this paper
• Androgen Excess and Hirsutism

  2010cites this paper
• Effect of metformin taken in the ‘fresh’ in vitro fertilization/intracytoplasmic sperm injection cycle upon subsequent frozen embryo replacement in women with polycystic ovary syndrome

  2010cites this paper
• Ovulation Induction in Anovulatory Patients with Polycystic Ovary Syndrome

  2010cites this paper
• Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial.

  2010cites this paper
• Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome.

  2010cites this paper
• Effect of Metformin on Hormonal and Biochemical Profile in PCOS Before and After Therapy

  2010cites this paper
• Effect of Treatment with Metformin on Omentin-1, Ghrelin and other Biochemical, Clinical Features in PCOS Patients.

  2010cites this paper
• Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome.

  2010cites this paper
• Fertility treatment in women with polycystic ovary syndrome: a decision analysis of different oral ovulation induction agents.

  2010cites this paper
• Use of Metformin in Clomiphene Citrate (CC) Resistant Polycystic Ovary Syndrome (PCOS)

  2009cites this paper
• The use of metformin in the management of polycystic ovary syndrome and associated anovulatory infertility: The current evidence

  2009cites this paper
• Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction, achievement of pregnancy, and live birth in Asian women with polycystic ovary syndrome: a randomized controlled trial.

  2009cites this paper
• Possible metformin effect on adrenal androgens during pretreatment and IVF cycle in women with polycystic ovary syndrome.

  2009cites this paper
• Supervised short-term nutrition and exercise promotes weight loss in overweight and obese patients with polycystic ovary syndrome.

  2009cites this paper
• The Risks of Cardiovascular Disease and Diabetes in the Polycystic Ovary Syndrome

  2009cites this paper
• Ovulation induction in polycystic ovary syndrome

  2009cites this paper
• Metformin Does Not Improve the Reproductive or Metabolic Profile in Women With Polycystic Ovary Syndrome (PCOS)

  2009cites this paper